DUBLIN, Calif.--(BUSINESS WIRE)--SuperGen, Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated to discovery and development of novel cancer therapies, announced that it will release its 2010 fourth quarter and fiscal year-end results on Monday, February 28, 2011. SuperGen's management team will provide details of the Company's financial results, and provide financial guidance for fiscal year 2011.
